Carl Walsh
Carl Walsh, a 59-year-old from Birmingham, has been participating in a clinical trial for a new cancer treatment after traditional therapies failed to manage his tongue cancer. Since beginning the trial in July, he has experienced significant improvements in his condition, including reduced swelling and pain, allowing him to regain some normalcy in his daily life.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Brazil:
Carl Walsh, a 59-year-old resident of Birmingham, shares how the treatment has improved his quality of life after being diagnosed with tongue cancer.
9
United Kingdom:
Carl Walsh, a patient with tongue cancer, shared his positive experience with the trial treatment amivantamab.
9